It was also observed that miR‐552 targeted AJAP1. By inhibiting AJAP1, miR‐552 promoted HCC cell proliferation, migration and invasion in vitro by regulating EMT and stimulated tumour growth in in vivo. Here, AJAP1 is linked to neoplasm.